FMP
BB Biotech AG
BBZA.DE
XETRA
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
43.4 EUR
0.15 (0.346%)
About
ceo
N/A
sector
Healthcare
industry
Biotechnology
website
https://www.bbbiotech.ch/en/bb-biotech/
exchange
XETRA
Description
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
CIK
N/A
ISIN
CH0038389992
CUSIP
N/A
Address
Seestrasse 16
Phone
41 44 267 67 00
Country
CH
Employee
10
IPO Date
Jun 29, 2020
Summary
CIK
-
Exchange
XETRA
Industry
Biotechnology
Sector
Healthcare
CUSIP
-
ISIN
CH0038389992
Country
CH
Price
43.4
Beta
0.83
Volume Avg.
24.29k
Market Cap
2.38B
Shares
-
52-Week
41.05-52.6
DCF
-7.29
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-11.24
P/B
-
Website
https://www.bbbiotech.ch/en/bb-biotech/
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest BBZA.DE News
It looks like there's no news available.
